Are Doctors the Best People to Manage Gout? Is There a Role for Nurses and Pharmacists?
Purpose of Review
To discuss alternate models of long-term gout management
Nurse-led care of gout appears to improve the uptake of and adherence to urate-lowering treatment in a research setting. Less impressive improvements were achieved with pharmacist-led remote management of gout; however, both strategies were more effective than usual primary care provider management of gout.
Individualised education about gout, patient involvement in decision-making, and access to trained support in managing side-effects and gout flares can improve the uptake of fine and adherence to urate-lowering treatment. This may be best achieved with nurse-led care of gout. However, further research is required to evaluate if the model of nurse-led care of gout can be implemented in routine clinical practice and in different healthcare systems.
KeywordsGout Urate-lowering treatment Nurse-led care Pharmacist-led care
Compliance with Ethical Standards
Conflicts of Interest
Dr. Abhishek has received departmental research grants from AstraZeneca and Oxford Immunotech and has received speaker fees from Menarini pharmaceuticals.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.• Kuo C-F, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2014;74(4):661–7. https://doi.org/10.1136/annrheumdis-2013-204463. Epidemiology of gout is described in this study CrossRefPubMedPubMedCentralGoogle Scholar
- 4.Andres M, Quintanilla MA, Sivera F, Sanchez-Paya J, Pascual E, Vela P, et al. Silent monosodium urate crystal deposits are associated with severe coronary calcification in asymptomatic hyperuricemia: an exploratory study. Arthr Rheumatol= (Hoboken, NJ). 2016;68(6):1531–9. https://doi.org/10.1002/art.39581.Google Scholar
- 7.• Abhishek A, Valdes AM, Zhang W, Doherty M. Association of serum uric acid and disease duration with frequent gout attacks: a case-control study. Arthritis care & research. 2016;68(10):1573–7. https://doi.org/10.1002/acr.22855. Longer disease duration and higher serum urate assiciates with gout floves CrossRefGoogle Scholar
- 10.Parsons S, Ingram, M., Clarke-Cornwell, M. A., Symmons, D. P. A heavy burden. In: A heavy burden. The University of Manchester, Manchester. 2011. Accessed 23/05/2017 2017.Google Scholar
- 11.•• Abhishek A, Jenkins W, La-Crette J, Fernandes G, Doherty M. Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study. Rheumatol (Oxford, England). 2017;56(4):529–33. https://doi.org/10.1093/rheumatology/kew395. Demonstrates long-term adherence and persistence of urate lowering treatment Google Scholar
- 13.• Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England. JAMA. 2014;312(24):2684–6. https://doi.org/10.1001/jama.2014.14484. Demonstrates poor urate lowering prescription rates in UK gout patients CrossRefPubMedGoogle Scholar
- 15.Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatol (Oxford, England). 2007;46(8):1372–4. https://doi.org/10.1093/rheumatology/kem056a.CrossRefGoogle Scholar
- 16.Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu GK, Kirbas I, et al. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol : CJASN. 2011;6(8):1887–94. https://doi.org/10.2215/cjn.11451210.CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Chen JH, Lan JL, Cheng CF, Liang WM, Lin HY, Tsay GJ, et al. Effect of urate-lowering therapy on the risk of cardiovascular disease and all-cause mortality in patients with gout: a case-matched cohort study. J Rheumatol. 2015;42(9):1694–701. https://doi.org/10.3899/jrheum.141542.CrossRefPubMedGoogle Scholar
- 18.Chen JH, Lan JL, Cheng CF, Liang WM, Lin HY, Tsay GJ, et al. Effect of urate-lowering therapy on all-cause and cardiovascular mortality in hyperuricemic patients without gout: a case-matched cohort study. PLoS One. 2015;10(12):e0145193. https://doi.org/10.1371/journal.pone.0145193.CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Bose B, Badve SV, Hiremath SS, Boudville N, Brown FG, Cass A, et al. Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dialysis Trans : Off Publ Eur Dialysis Trans Assoc-Eur Renal Assoc. 2014;29(2):406–13. https://doi.org/10.1093/ndt/gft378.CrossRefGoogle Scholar
- 27.• Chandratre P, Mallen CD, Roddy E, Liddle J, Richardson J. “You want to get on with the rest of your life”: a qualitative study of health-related quality of life in gout. Clin Rheumatol. 2016;35(5):1197–205. https://doi.org/10.1007/s10067-015-3039-2. Qualitative study of impact of gout on patients CrossRefPubMedGoogle Scholar
- 28.Te Karu L, Bryant L, Elley CR. Maori experiences and perceptions of gout and its treatment: a kaupapa Maori qualitative study. J Prim Health Care. 2013;5(3):214–22.Google Scholar
- 29.• Duyck SD, Petrie KJ, Dalbeth N. “You don’t have to be a drinker to get gout, but it helps”: a content analysis of the depiction of gout in popular newspapers. Arthritis Care & Research. 2016;68(11):1721–5. https://doi.org/10.1002/acr.22879. Qualitative study of impact of gout on patients CrossRefGoogle Scholar
- 41.•• Doherty M, Jenkins W, Richardson H, Abhishek A, Ashton D, Barclay C, et al. OP0268 nurse-led care versus general practitioner care of people with gout: a UK community-based randomised controlled trial. Ann Rheum Dis. 2017;76(Suppl 2):167. https://doi.org/10.1136/annrheumdis-2017-eular.5006. 2 year RCT of nurse led versus usual caneg gout Google Scholar
- 42.•• Goldfien RD, Ng MS, Yip G, Hwe A, Jacobson A, Pressman A, et al. Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study. BMJ Open. 2014;4(1):e003627. https://doi.org/10.1136/bmjopen-2013-003627. Describes pharmacist management of gout CrossRefPubMedPubMedCentralGoogle Scholar
- 43.•• Goldfien R, Pressman A, Jacobson A, Ng M, Avins A. A pharmacist-staffed virtual gout management clinic for achieving target serum uric acid levels: a randomized clinical trial. Permanente J. 2016;20(3):18–23. https://doi.org/10.7812/tpp/15-234.. RCT of remote monitoring and treatment of gout by pharmacist Google Scholar
- 44.•• Mikuls, TR CT, Rashid N, Levy GD, Kerimian A, Low K, Coburn B, Redden DT, Bridges SL Jr., Saag KG, Curtis JR. A pragmatic cluster-randomized controlled trial of an automated, pharmacy-based intervention to optimize allopurinol therapy in gout [abstract]. Arthritis Rheumatol 2015;67(Suppl 10). Ongoing cluster RCT of gout management Google Scholar
- 45.•• Fields TR, Rifaat A, Yee AMF, Ashany D, Kim K, Tobin M, et al. Pilot study of a multidisciplinary gout patient education and monitoring program. Semin Arthritis Rheum. 2017;46(5):601–8. https://doi.org/10.1016/j.semarthrit.2016.10.006. Patient education improves uptake of ULT CrossRefPubMedGoogle Scholar